See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

Hybrid Revascularization: The Emory Approach

Presenter: John Puskas

October 23, 2012

Presentation TCT 2012

TCT-73. Non-Invasive Evaluation of Coronary Artery Collateral Flow Using Computed Tomographic Angiography

Presenter: Jin-Ho Choi

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

Presenter: Jai-Wun Park

October 23, 2012

Presentation TCT 2012

When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR?

Presenter: Michael Rinaldi

October 23, 2012

Presentation TCT 2012

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

Presenter: Robert Cottone

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

Respicardia

Presenter: Robin Germany

October 23, 2012

Presentation TCT 2012

Orsiro (BIOTRONIK) Program Update

Presenter: Stephan Windecker

October 23, 2012

Advertisement

Slides

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Hybrid Revascularization: The Emory Approach

TCT-73. Non-Invasive Evaluation of Coronary Artery Collateral Flow Using Computed Tomographic Angiography

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR?

Design of a Fully Drug-Eluting Bioabsorbable Scaffold with EPC-Capture Technology

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Respicardia

Orsiro (BIOTRONIK) Program Update

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content